Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000066

President, Research & Develop. sold 4,109 shares at an average $20.03 ($82,300)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2024-11-11 Sale 10b5-1 −1,409 $20.01 $28,191 163,588 D: show line 1 in the form
Sethuraman Natarajan President, Research & Develop. 2024-11-13 Sale 10b5-1 −2,700 $20.04 $54,109 160,888 D: show line 2 in the form
Open-market sales · 4,109 sh · avg $20.03 · $82,300
Loading xslF345X05/wk-form4_1731534539.xml…